Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2014 January;80(1) > Minerva Anestesiologica 2014 January;80(1):39-47

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

ORIGINAL ARTICLES  FREEfree


Minerva Anestesiologica 2014 January;80(1):39-47

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Accuracy of leptin serum level in diagnosing ventilator-associated pneumonia: a case-control study

Parmentier-Decrucq E. 1, 2, Nseir S. 1, 2, Makris D. 3, Desrousseaux B. 1, Soudan B. 2, 4, Favory R. 1, 2, Mathieu D. 1, 2

1 Intensive Care Unit, Calmette Hospital, University Hospital of Lille, Lille, France; 2 University of Lille Nord de France, Lille, France; 3 Intensive Care Unit, University Hospital of Larisa, University of Thessaly, Larisa, Greece; 4 Biochemistry and Molecular Biology Laboratory, Pathology and Biology Center, University Hospital of Lille, Lille, France


FULL TEXT  


Background: Undernutrition causes a reduction of body-fat mass and a decrease in the circulating concentration of leptin which impairs the production of proinflammatory cytokines and increases the incidence of infectious diseases. The main objective of this study was to determine whether leptin deficiency is a risk factor for ventilator-associated pneumonia (VAP).
Methods: This prospective observational case-control study was conducted in a university ICU during a 2-year period. Patients with VAP (cases) were matched (1:1) to patients without VAP (controls) according to all the following criteria: age, gender, SAPS II, and duration of ICU stay before VAP occurrence. In all patients leptin, C-reactive protein (CRP) and procalcitonin (PCT) were measured at ICU admission, and twice a week. In addition, in cases, leptin, CRP and PCT were also measured on the day of VAP diagnosis.
Results: Eighty-six cases were matched with 86 controls. No significant difference was found in leptin and PCT levels between cases and controls. CRP level was significantly higher on the day of VAP in cases compared with controls (99 vs. 48 mg/L, P=0.001). Combination of CRP-leptin (CRP ≥78 mg/L and leptin ≥6.2 ng/mL on the day of VAP) was significantly (P=0.009) associated with VAP in univariate analysis. Multivariate analysis identified the combination of CRP-leptin (OR [95% CI] 3.08 [1.18-8.04], P=0.003), LOD score (1.27 [1.08-1.48], P=0.003), neuromuscular-blockers use (6.6 [2.03-21.7], P=0.002), and reintubation (3.3 [1.14-9.6], P=0.027) as independent risk factors for VAP.
Conclusion: In our study, leptin level was not associated with VAP occurrence. Further studies are needed to confirm our results, and to define the exact inflammatory role of leptin, and its interest as a biomarker in ICU patients.

top of page

Publication History

Cite this article as

Corresponding author e-mail

s-nseir@chru-lille.fr